Bibliographic Details
| Title: |
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD. |
| Authors: |
Sorella, S., Assanto, G. M., D'Elia, Gianna Maria, Annechini, Giorgia, Totaro, Matteo, Celia, Renata, Bruno, Leonardo, Placidi, Fabio, Martelli, M., Del Giudice, I. |
| Source: |
Leukemia & Lymphoma; Dec2024, Vol. 65 Issue 12, p1913-1916, 4p |
| Subject Terms: |
POSTERIOR leukoencephalopathy syndrome, ANAPLASTIC large-cell lymphoma, PROGRESSIVE multifocal leukoencephalopathy, VASCULAR endothelial growth factors, CLINICAL trials, FEBRILE neutropenia, LEUKOENCEPHALOPATHIES |
| Abstract: |
The article discusses a case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD. The patient experienced neurological symptoms and imaging abnormalities, leading to the diagnosis of PRES. The case highlights the importance of promptly recognizing and managing atypical adverse events associated with this treatment regimen, especially in elderly patients. Further research is needed to identify potential risk factors and preventive measures for such complications in patients undergoing similar treatments. [Extracted from the article] |
|
Copyright of Leukemia & Lymphoma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
